Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs.
第一作者:
Wenchang,Guo
第一单位:
Department of Biochemistry and Molecular Medicine,,University of California Davis, Sacramento, California 95817, USA.
作者:
主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞凋亡(Apoptosis);苯咪唑类(Benzimidazoles);细胞系, 肿瘤(Cell Line, Tumor);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);人类(Humans);干扰素γ(Interferon-gamma);白细胞介素2(Interleukin-2);淋巴瘤, T细胞, 皮肤(Lymphoma, T-Cell, Cutaneous);小鼠(Mice);小鼠, 裸(Mice, Nude);微RNAs(MicroRNAs);模型, 分子(Models, Molecular);肿瘤移植(Neoplasm Transplantation);磷酰化(Phosphorylation);前体T细胞淋巴母细胞白血病淋巴瘤(Precursor T-Cell Lymphoblastic Leukemia-Lymphoma);蛋白酪氨酸激酶类(Protein-Tyrosine Kinases);喹唑啉类(Quinazolines);T淋巴细胞(T-Lymphocytes);移植, 异种(Transplantation, Heterologous);增量调节(Up-Regulation)
DOI
10.1124/mol.112.079889
PMID
22899868
发布时间
2025-02-13
- 浏览23

Molecular pharmacology
938-47页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文